As filed with the Securities and Exchange Commission on June 19, 1998
                                                    Registration No. 333-_______

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                                                       
                                    FORM S-8
                             REGISTRATION STATEMENT
                                     UNDER
                           THE SECURITIES ACT OF 1933  

                              Possis Medical, Inc.
             (Exact name of registrant as specified in its charter)

              Minnesota                                     41-0783184
     (State or other jurisdiction                          (I.R.S. Employer
   of incorporation or organization)                      Identification No.)

     9055 Evergreen Boulevard N.W.
         Minneapolis, Minnesota                               55433-8003
(Address of Principal Executive Offices)                      (Zip Code)

                Possis Medical, Inc. 1992 Stock Compensation Plan
                            (full title of the plan)

              Robert G. Dutcher                            Copy to:
   President and Chief Executive Officer             Amy E. Ayotte, Esq.
             Possis Medical, Inc.                   Dorsey & Whitney LLP
        9055 Evergreen Boulevard N.W.              Pillsbury Center South
        Minneapolis, Minnesota 55433               220 South Sixth Street
               (612) 780-4555                Minneapolis, Minnesota  55402-1498
            (Name, address, including zip code, and telephone number,
                   including area code, of agent for service)
 
                                 (612) 780-4555
          (Telephone number, including area code, of agent for service)
                              ____________________

     Approximate date of commencement of proposed sale to the public:  from time
to time after the effective date of this Registration Statement.

CALCULATION OF REGISTRATION FEE
  Title of each                    Proposed          Proposed
    class of                       Maximum           Maximum         Amount of
  Securities to   Amount to be     Offering         Aggregate      Registration
  be registered    registered   Price per Share   Offering Price       Fee
                      (1)            (2)               (2)      

  Common Stock
($.40 par value)   1,400,000       $10.125         $14,175,000        $4,182

     (1) The number of shares being  registered  represents the number of shares
of Common Stock that may be issued  pursuant to the Possis  Medical,  Inc.  1992
Stock Compensation Plan (the "Plan") in addition to shares previously registered
under the Plan.

     (2) Estimated  solely for the purpose of calculating the  registration  fee
pursuant to Rule 457(h)(1), based upon the average of the high and low prices of
the Common Stock as reported by the Nasdaq National Market on June 15, 1998.

<PAGE>


                                     PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Registration of Additional Securities

     Pursuant  to  Section  E of the  General  Instructions  to Form  S-8,  this
Registration  Statement  incorporates by reference the Registration Statement on
Form S-8 relating to the Plan filed with the Securities and Exchange  Commission
on December 30, 1992 (File No. 33-56728).

Item 3.   Incorporation of Documents by Reference.

     The following documents, which have been filed by Possis Medical, Inc. (the
"Company") with the Securities and Exchange Commission (the  "Commission"),  are
incorporated by reference in this Registration Statement, as of their respective
dates:

     (a) The Company's Annual Report on Form 10-K for the fiscal year ended July
31, 1997;

     (b) The  Company's  Quarterly  Reports on Form 10-Q for the quarters  ended
October 31, 1997, January 31, 1998 and April 30, 1998; and

     (c) The descriptions of the Company's common stock, $.40 par value, and the
Company's   Preferred  Share  Purchase  Rights  contained  in  any  Registration
Statement of the Company  filed under the  Securities  Exchange Act of 1934,  as
amended (the "1934 Act"),  and any  amendment or report filed for the purpose of
updating such descriptions subsequent to the date of this Prospectus.

     All documents filed by the Company pursuant to Sections 13(a), 13(c), 14 or
15(d) of the 1934 Act,  subsequent to the date hereof and prior to the filing of
a  post-effective  amendment which indicates that all securities  offered hereby
have been sold or which deregisters all securities  remaining  unsold,  shall be
deemed to be incorporated  by reference  herein and to be a part hereof from the
respective dates of filing of such documents.

Item 5.   Interests of Named Experts and Counsel

          Not applicable.

Item 8.   Exhibits

 Exhibit No.  Description

     4.1      Rights Agreement, dated as of December 12, 1996, between the 
              Company and Norwest Bank Minnesota, National Association, 
              including the Form of Right Certificate attached as Exhibit B 
              thereto (incorporated by reference to Exhibit 1 tothe Company's 
              Registration Statement on Form 8-A filed December 12, 1996).

     5.1      Opinion of Dorsey & Whitney LLP.

    23.1      Consent of Deloitte & Touche LLP.

    23.2      Consent of Dorsey & Whitney LLP (included in Exhibit5.1).

    24.1      Powers of Attorney.

<PAGE>

Item 9.   Undertakings.

     A. Post-Effective Amendments.

              The undersigned issuer hereby undertakes:

     (1) To file,  during any period in which  offers or sales are being made, a
post-effective amendment to this registration statement:

     (a)  To  include  any  prospectus  required  by  Section  10(a)(3)  of  the
Securities Act of 1933;

     (b) To  reflect in the  prospectus  any facts or events  arising  after the
effective  date of the  registration  statement  (or most recent  post-effective
amendment  thereof)  which,  individually  or  in  the  aggregate,  represent  a
fundamental  change in the information set forth in the registration  statement.
Notwithstanding the foregoing,  any increase or decrease in volume of securities
offered (if the total dollar value of  securities  offered would not exceed that
which  was  registered)  and any  deviation  from  the  low or  high  end of the
estimated  maximum  offering  range may be reflected  in the form of  prospectus
filed with the  Commission  pursuant  to Rule 424(b) if, in the  aggregate,  the
changes in volume and price  represent  no more than a 20% change in the maximum
aggregate  offering price set forth in the  "Calculation  of  Registration  Fee"
table in the effective registration statement.

     (c) To  include  any  material  information  with  respect  to the  plan of
distribution  not  previously  disclosed  in the  registration  statement or any
material change to such information in the registration statement;

provided,  however,  that subparagraphs (a) and (b) above will not apply if  the
information  required  to be  included in a   post-effective  amendment by those
subparagraphs  is contained in periodic  reports  filed with or furnished to the
Commission  by the  registrant  pursuant  to Section 13 or Section  15(d) of the
Securities  Exchange  Act of 1934 that are  incorporated  by  reference  in this
registration statement.

     (2) That, for the purpose of determining any liability under the Securities
Act of 1933,  each  such  post-effective  amendment  shall be deemed to be a new
registration  statement  relating to the  securities  offered  therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

     (3) To remove from registration by means of a post-effective  amendment any
of the securities being registered which remain unsold at the termination of the
offering.

     B. Subsequent Documents Incorporated by Reference.

     The  undersigned   registrant  hereby  undertakes  that,  for  purposes  of
determining  any liability  under the Securities Act of 1933, each filing of the
registrant's  annual  report  pursuant to Section  13(a) or Section 15(d) of the
Securities  Exchange  Act of  1934  that is  incorporated  by  reference  in the
registration  statement  shall  be  deemed  to be a new  registration  statement
relating to the securities offered therein,  and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.

     C. Claims for Indemnification.

     Insofar as indemnification for liabilities arising under the Securities Act
of 1933 may be permitted to directors,  officers and controlling  persons of the
registrant pursuant to the foregoing  provisions,  or otherwise,  the registrant
has been advised that in the opinion of the Securities  and Exchange  Commission
such  indemnification  is against  public policy as expressed in the Act and is,
therefore,  unenforceable. In the event that a claim for indemnification against
such liabilities  (other than the payment by the registrant of expenses incurred
or paid by a director,  officer or other controlling person of the registrant in
the  successful  defense of any action,  suit or proceeding) is asserted by such
director,  officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter
has been  settled by  controlling  precedent,  submit to a court of  appropriate
jurisdiction the question whether such  indemnification  by it is against public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.

<PAGE>

                                   SIGNATURES

     Pursuant to the  requirements of the Securities Act of 1933, the registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on Form S-8 and has  duly  caused  this  Registration
Statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized, in the City of Minneapolis, State of Minnesota, on June 19, 1998.

                                      POSSIS MEDICAL, INC.

                                      By   /s/ Robert G. Dutcher 
                                         Robert G. Dutcher
                                         President and Chief Executive Officer

     Pursuant  to  the   requirements  of  the  Securities  Act  of  1933,  this
Registration  Statement  has  been  signed  by  the  following  persons  in  the
capacities and on the date indicated.

         Name                               Title                     Date      


 /s/ Robert G. Dutcher      President, Chief Executive Officer    June 19, 1998
 Robert G. Dutcher          and Director
                            (Principal Executive Officer)

 /s/ Russel E. Carlson      Vice President, Finance and Chief     June 19, 1998
 Russel E. Carlson          Financial Officer
                            (Principal Financial and Accounting Officer)

 *                          Chairman of the Board
 Donald C. Wegmiller

 *                          Director
 Dean Belbas

 *                          Director
 Seymour J. Mansfield

 *                          Director
 Demetre Nicoloff, MD

 *                          Director
 Ann M. Possis

*By:    /s/ Robert G. Dutcher                                     June 19, 1998
        Robert G. Dutcher
        Attorney-in-fact**

__________
     **  Executed  on  behalf of the  indicated  persons  by  Robert G.  Dutcher
pursuant to the Powers of Attorney included as Exhibit 24.1 to this registration
statement.

<PAGE>

                                  EXHIBIT INDEX


Exhibit Number                     Description

   5.1         Opinion of Dorsey & Whitney LLP.

  23.1         Consent of Deloitte & Touche LLP.

  23.2         Consent of Dorsey & Whitney LLP (included in Exhibit5.1 to this
               Registration Statement).

  24.1         Powers of Attorney.

<PAGE>

                                                                   Exhibit 5.1

                      [Letterhead of Dorsey & Whitney LLP]
                              DORSEY & WHITNEY LLP
                             Pillsbury Center South
                             220 South Sixth Street
                        Minneapolis, Minnesota 55402-1498
                            Telephone: (612) 340-2600
                               Fax: (612) 340-2868



Possis Medical, Inc.
9055 Evergreen Boulevard N.W.
Minneapolis, Minnesota 55433

Ladies and Gentlemen:

     We have acted as counsel to Possis Medical,  Inc., a Minnesota  corporation
(the  "Company"),  in  connection  with a  Registration  Statement  on Form  S-8
(the"Registration  Statement")  relating to the sale by the Company from time to
time of up to 1,400,000 shares of Common Stock, $.40 par value per share, of the
Company  (the  "Shares"),   issuable   pursuant  to  the  Company's  1992  Stock
Compensation Plan (the "Plan").

     We have examined such  documents and have reviewed such questions of law as
we have  considered  necessary and  appropriate for the purposes of the opinions
set forth below.

     In rendering our opinions set forth below, we have assumed the authenticity
of all documents submitted to us as originals, the genuineness of all signatures
and the  conformity to authentic  originals of all documents  submitted to us as
copies. We have also assumed the legal capacity for all purposes relevant hereto
of all  natural  persons  and,  with  respect to all  parties to  agreements  or
instruments  relevant  hereto other than the Company,  that such parties had the
requisite power and authority  (corporate or otherwise) to execute,  deliver and
perform such agreements or instruments, that such agreements or instruments have
been duly authorized by all requisite action (corporate or otherwise),  executed
and delivered by such parties and that such  agreements or  instruments  are the
valid,  binding and enforceable  obligations of such parties. As to questions of
fact material to our opinions,  we have relied upon  certificates of officers of
the Company and of public officials.

     Based on the  foregoing,  we are of the  opinion  that the Shares have been
duly authorized and, upon issuance,  delivery and payment therefor in accordance
with  the  terms  of  the  Plan,  will  be  validly   issued,   fully  paid  and
nonassessable.

     Our  opinions  expressed  above  are  limited  to the laws of the  State of
Minnesota.

     We hereby  consent  to the  filing of this  opinion  as an  exhibit  to the
Registration Statement.


Date:   June 19, 1998
                                           Very truly yours,


                                           /s/ Dorsey & Whitney LLP


AEA

<PAGE>
                                                                  Exhibit 23.1

INDEPENDENT AUDITORS' CONSENT

     We consent to the incorporation by reference in this Registration Statement
of Possis  Medical,  Inc.,  on Form S-8 relating to the 1992 Stock  Compensation
Plan of our report,  dated August 29, 1997 on the 1997 financial  statements and
related  financial  statement  schedule,  appearing in the Annual Report on Form
10-K of Possis Medical, Inc., for the year ended July 31, 1997.



                                                 Deloitte & Touche LLP

Minneapolis, Minnesota
June16, 1998

<PAGE>
                                                                  Exhibit 24.1


                               POWERS OF ATTORNEY

     KNOW ALL  PERSONS  BY THESE  PRESENTS,  that each  person  whose  signature
appears below hereby  constitutes  and appoints  Robert G. Dutcher and Russel E.
Carlson,  and each of them, the undersigned's true and lawful  attorneys-in-fact
and  agents,  with  full  power  of  substitution  and  resubstitution,  for the
undersigned  and in his or her name,  place and stead, in any and all capacities
(including  the  undersigned's  capacity as a director  and/or officer of Possis
Medical,  Inc.), to sign a Registration Statement on Form S-8 of Possis Medical,
Inc.  ("Possis")  to  be  filed  under  the  Securities  Act  of  1933  for  the
registration  of 1,400,000  shares of Common Stock of Possis in connection  with
the  Possis  Medical,  Inc.  1992  Stock  Compensation  Plan,  and  any  and all
amendments (including post-effective amendments) to such Registration Statement,
and to file  the  same,  with all  exhibits  thereto,  and  other  documents  in
connection therewith, with the Securities and Exchange Commission, granting unto
said attorneys-in-fact and agents, and each of them, full power and authority to
do and perform each and every act and thing  requisite  and necessary to be done
in about the premises,  as fully to all intents and purposes as the  undersigned
might or could do in  person,  hereby  ratifying  and  confirming  all that said
attorneys-in-fact and agents or any of them, or their substitutes,  may lawfully
do or cause to be done by virtue hereof.

         Name                       Title                       Date


/s/ Donald C. Wegmiller     Chairman of the Board           June 18, 1998
Donald C. Wegmiller


/s/ Dean Belbas             Director                        June 18, 1998
Dean Belbas


/s/Seymour J. Mansfield     Director                        June 18, 1998
Seymour J. Mansfield


/s/ Demetre Nicoloff, MD    Director                        June 18, 1998
Demetre Nicoloff, MD


/s/Ann M. Possis            Director                        June 18, 1998
Ann M. Possis


/s/ Robert G. Dutcher       President, Chief Executive      June 18, 1998
Robert G. Dutcher           Officer and Director


/s/ Russel E. Carlson       Vice President of Finance and   June 18, 1998
Russel E. Carlson           Chief Financial Officer
[{"type": "S-8", "sequence": "1", "description": "FORM S-8 REGISTRATION STATEMENT", "secsgml_size_bytes": 18123}]
{"company-data": {"conformed-name": "POSSIS MEDICAL INC", "cik": "0000079677", "assigned-sic": "3842", "irs-number": "410783184", "state-of-incorporation": "MN", "fiscal-year-end": "0731"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-57289", "film-number": "98651217"}, "business-address": {"street1": "9055 EVERGREEN BLVD N W", "city": "MINNEAPOLIS", "state": "MN", "zip": "55433-8003", "phone": "6125451471"}, "mail-address": {"street1": "9055 EVERGREEN BLVD N W", "city": "MINNAPOLIS", "state": "MN", "zip": "55433-8003"}, "former-company": {"former-conformed-name": "POSSIS MACHINE CORP", "date-changed": "19721106"}}
As filed with the Securities and Exchange Commission on June 19, 1998
                                                    Registration No. 333-_______

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                                                       
                                    FORM S-8
                             REGISTRATION STATEMENT
                                     UNDER
                           THE SECURITIES ACT OF 1933  

                              Possis Medical, Inc.
             (Exact name of registrant as specified in its charter)

              Minnesota                                     41-0783184
     (State or other jurisdiction                          (I.R.S. Employer
   of incorporation or organization)                      Identification No.)

     9055 Evergreen Boulevard N.W.
         Minneapolis, Minnesota                               55433-8003
(Address of Principal Executive Offices)                      (Zip Code)

                Possis Medical, Inc. 1992 Stock Compensation Plan
                            (full title of the plan)

              Robert G. Dutcher                            Copy to:
   President and Chief Executive Officer             Amy E. Ayotte, Esq.
             Possis Medical, Inc.                   Dorsey & Whitney LLP
        9055 Evergreen Boulevard N.W.              Pillsbury Center South
        Minneapolis, Minnesota 55433               220 South Sixth Street
               (612) 780-4555                Minneapolis, Minnesota  55402-1498
            (Name, address, including zip code, and telephone number,
                   including area code, of agent for service)
 
                                 (612) 780-4555
          (Telephone number, including area code, of agent for service)
                              ____________________

     Approximate date of commencement of proposed sale to the public:  from time
to time after the effective date of this Registration Statement.

CALCULATION OF REGISTRATION FEE
  Title of each                    Proposed          Proposed
    class of                       Maximum           Maximum         Amount of
  Securities to   Amount to be     Offering         Aggregate      Registration
  be registered    registered   Price per Share   Offering Price       Fee
                      (1)            (2)               (2)      

  Common Stock
($.40 par value)   1,400,000       $10.125         $14,175,000        $4,182

     (1) The number of shares being  registered  represents the number of shares
of Common Stock that may be issued  pursuant to the Possis  Medical,  Inc.  1992
Stock Compensation Plan (the "Plan") in addition to shares previously registered
under the Plan.

     (2) Estimated  solely for the purpose of calculating the  registration  fee
pursuant to Rule 457(h)(1), based upon the average of the high and low prices of
the Common Stock as reported by the Nasdaq National Market on June 15, 1998.
PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Registration of Additional Securities

     Pursuant  to  Section  E of the  General  Instructions  to Form  S-8,  this
Registration  Statement  incorporates by reference the Registration Statement on
Form S-8 relating to the Plan filed with the Securities and Exchange  Commission
on December 30, 1992 (File No. 33-56728).

Item 3.   Incorporation of Documents by Reference.

     The following documents, which have been filed by Possis Medical, Inc. (the
"Company") with the Securities and Exchange Commission (the  "Commission"),  are
incorporated by reference in this Registration Statement, as of their respective
dates:

     (a) The Company's Annual Report on Form 10-K for the fiscal year ended July
31, 1997;

     (b) The  Company's  Quarterly  Reports on Form 10-Q for the quarters  ended
October 31, 1997, January 31, 1998 and April 30, 1998; and

     (c) The descriptions of the Company's common stock, $.40 par value, and the
Company's   Preferred  Share  Purchase  Rights  contained  in  any  Registration
Statement of the Company  filed under the  Securities  Exchange Act of 1934,  as
amended (the "1934 Act"),  and any  amendment or report filed for the purpose of
updating such descriptions subsequent to the date of this Prospectus.

     All documents filed by the Company pursuant to Sections 13(a), 13(c), 14 or
15(d) of the 1934 Act,  subsequent to the date hereof and prior to the filing of
a  post-effective  amendment which indicates that all securities  offered hereby
have been sold or which deregisters all securities  remaining  unsold,  shall be
deemed to be incorporated  by reference  herein and to be a part hereof from the
respective dates of filing of such documents.

Item 5.   Interests of Named Experts and Counsel

          Not applicable.

Item 8.   Exhibits

 Exhibit No.  Description

     4.1      Rights Agreement, dated as of December 12, 1996, between the 
              Company and Norwest Bank Minnesota, National Association, 
              including the Form of Right Certificate attached as Exhibit B 
              thereto (incorporated by reference to Exhibit 1 tothe Company's 
              Registration Statement on Form 8-A filed December 12, 1996).

     5.1      Opinion of Dorsey & Whitney LLP.

    23.1      Consent of Deloitte & Touche LLP.

    23.2      Consent of Dorsey & Whitney LLP (included in Exhibit5.1).

    24.1      Powers of Attorney.
Item 9.   Undertakings.

     A. Post-Effective Amendments.

              The undersigned issuer hereby undertakes:

     (1) To file,  during any period in which  offers or sales are being made, a
post-effective amendment to this registration statement:

     (a)  To  include  any  prospectus  required  by  Section  10(a)(3)  of  the
Securities Act of 1933;

     (b) To  reflect in the  prospectus  any facts or events  arising  after the
effective  date of the  registration  statement  (or most recent  post-effective
amendment  thereof)  which,  individually  or  in  the  aggregate,  represent  a
fundamental  change in the information set forth in the registration  statement.
Notwithstanding the foregoing,  any increase or decrease in volume of securities
offered (if the total dollar value of  securities  offered would not exceed that
which  was  registered)  and any  deviation  from  the  low or  high  end of the
estimated  maximum  offering  range may be reflected  in the form of  prospectus
filed with the  Commission  pursuant  to Rule 424(b) if, in the  aggregate,  the
changes in volume and price  represent  no more than a 20% change in the maximum
aggregate  offering price set forth in the  "Calculation  of  Registration  Fee"
table in the effective registration statement.

     (c) To  include  any  material  information  with  respect  to the  plan of
distribution  not  previously  disclosed  in the  registration  statement or any
material change to such information in the registration statement;

provided,  however,  that subparagraphs (a) and (b) above will not apply if  the
information  required  to be  included in a   post-effective  amendment by those
subparagraphs  is contained in periodic  reports  filed with or furnished to the
Commission  by the  registrant  pursuant  to Section 13 or Section  15(d) of the
Securities  Exchange  Act of 1934 that are  incorporated  by  reference  in this
registration statement.

     (2) That, for the purpose of determining any liability under the Securities
Act of 1933,  each  such  post-effective  amendment  shall be deemed to be a new
registration  statement  relating to the  securities  offered  therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

     (3) To remove from registration by means of a post-effective  amendment any
of the securities being registered which remain unsold at the termination of the
offering.

     B. Subsequent Documents Incorporated by Reference.

     The  undersigned   registrant  hereby  undertakes  that,  for  purposes  of
determining  any liability  under the Securities Act of 1933, each filing of the
registrant's  annual  report  pursuant to Section  13(a) or Section 15(d) of the
Securities  Exchange  Act of  1934  that is  incorporated  by  reference  in the
registration  statement  shall  be  deemed  to be a new  registration  statement
relating to the securities offered therein,  and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.

     C. Claims for Indemnification.

     Insofar as indemnification for liabilities arising under the Securities Act
of 1933 may be permitted to directors,  officers and controlling  persons of the
registrant pursuant to the foregoing  provisions,  or otherwise,  the registrant
has been advised that in the opinion of the Securities  and Exchange  Commission
such  indemnification  is against  public policy as expressed in the Act and is,
therefore,  unenforceable. In the event that a claim for indemnification against
such liabilities  (other than the payment by the registrant of expenses incurred
or paid by a director,  officer or other controlling person of the registrant in
the  successful  defense of any action,  suit or proceeding) is asserted by such
director,  officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter
has been  settled by  controlling  precedent,  submit to a court of  appropriate
jurisdiction the question whether such  indemnification  by it is against public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.
SIGNATURES

     Pursuant to the  requirements of the Securities Act of 1933, the registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on Form S-8 and has  duly  caused  this  Registration
Statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized, in the City of Minneapolis, State of Minnesota, on June 19, 1998.

                                      POSSIS MEDICAL, INC.

                                      By   /s/ Robert G. Dutcher 
                                         Robert G. Dutcher
                                         President and Chief Executive Officer

     Pursuant  to  the   requirements  of  the  Securities  Act  of  1933,  this
Registration  Statement  has  been  signed  by  the  following  persons  in  the
capacities and on the date indicated.

         Name                               Title                     Date      

 /s/ Robert G. Dutcher      President, Chief Executive Officer    June 19, 1998
 Robert G. Dutcher          and Director
                            (Principal Executive Officer)

 /s/ Russel E. Carlson      Vice President, Finance and Chief     June 19, 1998
 Russel E. Carlson          Financial Officer
                            (Principal Financial and Accounting Officer)

 *                          Chairman of the Board
 Donald C. Wegmiller

 *                          Director
 Dean Belbas

 *                          Director
 Seymour J. Mansfield

 *                          Director
 Demetre Nicoloff, MD

 *                          Director
 Ann M. Possis

*By:    /s/ Robert G. Dutcher                                     June 19, 1998
        Robert G. Dutcher
        Attorney-in-fact**

__________
     **  Executed  on  behalf of the  indicated  persons  by  Robert G.  Dutcher
pursuant to the Powers of Attorney included as Exhibit 24.1 to this registration
statement.
EXHIBIT INDEX

Exhibit Number                     Description

   5.1         Opinion of Dorsey & Whitney LLP.

  23.1         Consent of Deloitte & Touche LLP.

  23.2         Consent of Dorsey & Whitney LLP (included in Exhibit5.1 to this
               Registration Statement).

  24.1         Powers of Attorney.
Exhibit 5.1

                      [Letterhead of Dorsey & Whitney LLP]
                              DORSEY & WHITNEY LLP
                             Pillsbury Center South
                             220 South Sixth Street
                        Minneapolis, Minnesota 55402-1498
                            Telephone: (612) 340-2600
                               Fax: (612) 340-2868

Possis Medical, Inc.
9055 Evergreen Boulevard N.W.
Minneapolis, Minnesota 55433

Ladies and Gentlemen:

     We have acted as counsel to Possis Medical,  Inc., a Minnesota  corporation
(the  "Company"),  in  connection  with a  Registration  Statement  on Form  S-8
(the"Registration  Statement")  relating to the sale by the Company from time to
time of up to 1,400,000 shares of Common Stock, $.40 par value per share, of the
Company  (the  "Shares"),   issuable   pursuant  to  the  Company's  1992  Stock
Compensation Plan (the "Plan").

     We have examined such  documents and have reviewed such questions of law as
we have  considered  necessary and  appropriate for the purposes of the opinions
set forth below.

     In rendering our opinions set forth below, we have assumed the authenticity
of all documents submitted to us as originals, the genuineness of all signatures
and the  conformity to authentic  originals of all documents  submitted to us as
copies. We have also assumed the legal capacity for all purposes relevant hereto
of all  natural  persons  and,  with  respect to all  parties to  agreements  or
instruments  relevant  hereto other than the Company,  that such parties had the
requisite power and authority  (corporate or otherwise) to execute,  deliver and
perform such agreements or instruments, that such agreements or instruments have
been duly authorized by all requisite action (corporate or otherwise),  executed
and delivered by such parties and that such  agreements or  instruments  are the
valid,  binding and enforceable  obligations of such parties. As to questions of
fact material to our opinions,  we have relied upon  certificates of officers of
the Company and of public officials.

     Based on the  foregoing,  we are of the  opinion  that the Shares have been
duly authorized and, upon issuance,  delivery and payment therefor in accordance
with  the  terms  of  the  Plan,  will  be  validly   issued,   fully  paid  and
nonassessable.

     Our  opinions  expressed  above  are  limited  to the laws of the  State of
Minnesota.

     We hereby  consent  to the  filing of this  opinion  as an  exhibit  to the
Registration Statement.

Date:   June 19, 1998
                                           Very truly yours,

                                           /s/ Dorsey & Whitney LLP

AEA
Exhibit 23.1

INDEPENDENT AUDITORS' CONSENT

     We consent to the incorporation by reference in this Registration Statement
of Possis  Medical,  Inc.,  on Form S-8 relating to the 1992 Stock  Compensation
Plan of our report,  dated August 29, 1997 on the 1997 financial  statements and
related  financial  statement  schedule,  appearing in the Annual Report on Form
10-K of Possis Medical, Inc., for the year ended July 31, 1997.

                                                 Deloitte & Touche LLP

Minneapolis, Minnesota
June16, 1998
Exhibit 24.1

                               POWERS OF ATTORNEY

     KNOW ALL  PERSONS  BY THESE  PRESENTS,  that each  person  whose  signature
appears below hereby  constitutes  and appoints  Robert G. Dutcher and Russel E.
Carlson,  and each of them, the undersigned's true and lawful  attorneys-in-fact
and  agents,  with  full  power  of  substitution  and  resubstitution,  for the
undersigned  and in his or her name,  place and stead, in any and all capacities
(including  the  undersigned's  capacity as a director  and/or officer of Possis
Medical,  Inc.), to sign a Registration Statement on Form S-8 of Possis Medical,
Inc.  ("Possis")  to  be  filed  under  the  Securities  Act  of  1933  for  the
registration  of 1,400,000  shares of Common Stock of Possis in connection  with
the  Possis  Medical,  Inc.  1992  Stock  Compensation  Plan,  and  any  and all
amendments (including post-effective amendments) to such Registration Statement,
and to file  the  same,  with all  exhibits  thereto,  and  other  documents  in
connection therewith, with the Securities and Exchange Commission, granting unto
said attorneys-in-fact and agents, and each of them, full power and authority to
do and perform each and every act and thing  requisite  and necessary to be done
in about the premises,  as fully to all intents and purposes as the  undersigned
might or could do in  person,  hereby  ratifying  and  confirming  all that said
attorneys-in-fact and agents or any of them, or their substitutes,  may lawfully
do or cause to be done by virtue hereof.

         Name                       Title                       Date

/s/ Donald C. Wegmiller     Chairman of the Board           June 18, 1998
Donald C. Wegmiller

/s/ Dean Belbas             Director                        June 18, 1998
Dean Belbas

/s/Seymour J. Mansfield     Director                        June 18, 1998
Seymour J. Mansfield

/s/ Demetre Nicoloff, MD    Director                        June 18, 1998
Demetre Nicoloff, MD

/s/Ann M. Possis            Director                        June 18, 1998
Ann M. Possis

/s/ Robert G. Dutcher       President, Chief Executive      June 18, 1998
Robert G. Dutcher           Officer and Director

/s/ Russel E. Carlson       Vice President of Finance and   June 18, 1998
Russel E. Carlson           Chief Financial Officer